Pyxis Oncology Inc. (NASDAQ: PYXS)
$3.56
+0.3600 ( +11.25% ) 851.3K
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Market Data
Open
$3.56
Previous close
$3.20
Volume
851.3K
Market cap
$209.64M
Day range
$3.18 - $3.63
52 week range
$1.35 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 17, 2023 |
10-q | Quarterly Reports | 81 | Nov 07, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |
8-k/a | 8K-related | 16 | Oct 27, 2023 |
4 | Insider transactions | 1 | Sep 28, 2023 |
4 | Insider transactions | 1 | Sep 27, 2023 |
4 | Insider transactions | 1 | Sep 27, 2023 |
4 | Insider transactions | 1 | Sep 26, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |